Last month, we wrote about T-cell immunity after scientists discovered some coronavirus patients recovered from COVID-19 infection, but mysteriously did NOT have any antibodies against the virus. Since then, they have learned a lot more about the other types of T-cell […]
Last week, President Trump signed an executive order banning US transactions with owners of TikTok and WeChat in 45 days. Citing national security concerns, President Trump the ban will make it unlawful for any US companies or citizens from making transactions […]
With global sales teams switching to remote work and field sales teams grounded for the foreseeable future, more companies are leveraging innovative technologies to remotely boost their sales and navigate the ever challenging business environment. Enter Gong, a San Francisco-based tech […]
As coronavirus pandemic continues to create uncertainty around the world, many fintech startup companies are struggling to stay afloat. According to market intelligence company CB Insights, the volume of funding rounds for the fintech sector has fallen 45 percent compared to Q4 […]
We’ve been trying to trace the origin of the coronavirus since March, but with limited success. As the mystery deepens over the source of coronavirus, three Chinese scientists said pangolins are a prime suspect, but a slew of genetic analyses […]
The last time we wrote about Zoom’s valuation was back in May when the video conferencing app was hovering around $50 billion in valuation. At the time, Zoom was worth more than the world’s 7 biggest airlines combined. Today, Zoom […]
Yesterday, Russia announced it has completed the clinical trials of a vaccine against covid-19 and will be made available for emergency use on health-care workers this fall. The clinical trials of the Russian vaccine were completed in less than two months […]
We covered SoftBank Group several times last year. 2019 was a terrible year for the Japanese technology giant that invests in unicorn tech startups including Uber, WeWork, Grab, Zume, among others. In 2019 alone, the SoftBank Vision Fund an $18 billion […]
As coronavirus pandemic continues to spread across the country with no sign of abating, millions of Americans are without jobs and many are struggling to pay their rents and mortgages. Till is a Washington, D.C.-based fintech platform with products aimed at […]
Researchers and companies struggle with access to AI-based drug discovery technology, due to overall cost and lack of expertise — something which requires computational scientists, drug discovery experts, software and systems engineers for AI and ML. Enter Atomwise, a San Francisco-based […]
Last month, we wrote about Moderna after the biotech giant announced it has begun the final-stage testing of its coronavirus vaccine. Moderna said its mRNA vaccine could be ready for use by the end of 2020. Today, the company received […]
Back in June, we wrote about Dr. Scott Atlas when the former chief of neuroradiology at Stanford University Medical Center and a senior fellow at Stanford’s Hoover Institution, said that the rise in coronavirus hospitalizations among young people is a good […]
The last time we covered SiFive was back in April 2018 when the California startup working to commercialize an open-source semiconductor technology raised $50.6 million to advance its Open RISC-V architecture based semiconductors. As demand for domain-specific architecture drives continued investment […]
Lumeon, a London, England-based digital health startup company providing care pathway management solutions to the healthcare industry, today announced that it has closed $30M in Series D funding led by new investors Optum Ventures and Endeavour Vision, with participation from current […]
The current rise in remote work brings cybersecurity challenges with increased reliance on remote access, collaboration and productivity tools. Enter Blumira, an emerging cybersecurity startup based in Ann Arbor, Michigan that addresses these challenges by automating security operation workflows to enable customers […]